[Evaluation of the effectiveness of differentiated therapy in patients with chronic erosions of the gastric mucosa].
Potentialities of differentiated therapy of patients with recurrent chronic erosions using medicinal and nonmedicinal methods in 119 patients were studied. During differentiated therapy one should take into account the condition of pathological microflora and circulatory disturbances. At the first stage routine therapy with subsequent incorporation of biogastrone was employed. At the second stage in the absence of a therapeutic effect local administration of a granulocytic concentrate was performed, and in insufficient effectiveness, electrocoagulation of chronic erosions of the gastric mucosa was indicated. The use of differentiated therapy contributed to a favorable prognosis of disease in these patients.
D000328:Adult; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D002229:Carbenoxolone / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D004564:Electrocoagulation; D005260:Female; D005753:Gastric Mucosa / Q000473:pathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000627:therapeutic use; D013276:Stomach Ulcer / Q000473:pathology / Q000628:therapy*
D000897:Anti-Ulcer Agents; D010936:Plant Extracts; D002229:Carbenoxolone
Otsenka éffektivnosti differentsirovannoĭ terapii u bol'nykh khronicheskimi éroziiami slizistoĭ zheludka.